IVGPS Trademark

Trademark Overview


On Wednesday, August 24, 2022, a trademark application was filed for IVGPS with the United States Patent and Trademark Office. The USPTO has given the IVGPS trademark a serial number of 97562911. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Sunday, October 1, 2023. This trademark is owned by Kelonia Therapeutics, Inc.. The IVGPS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical, medical and clinical preparations for use in cell and gene therapy; pharmaceutical, medical and clinical preparations for use in cell and gene therapy for treatment of cancer and genetic diseases; Cell and gene therapy vectors for treatment of cancer and genetic diseases; therapeutic preparations for enhancing the targeting, delivery, and effectiveness of cancer treatments; t-cells for medical and therapeutic use; cell-based immunotherapeutic treatment by way of genetically modified cells for use in human therapeutics and the treatment of cancer and genetic diseases; pharmaceutical and biological preparations based on gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy for use in human therapeutics, namely, therapeutic pharmaceuticals developed through genome modifications for the treatment of cancer and genetic diseases

Scientific and medical research services in the field of cell and gene therapies; Scientific and medical research services in the field of cell and gene therapies using engineered viral vectors
ivgps

General Information


Serial Number97562911
Word MarkIVGPS
Filing DateWednesday, August 24, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateSunday, October 1, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical, medical and clinical preparations for use in cell and gene therapy; pharmaceutical, medical and clinical preparations for use in cell and gene therapy for treatment of cancer and genetic diseases; Cell and gene therapy vectors for treatment of cancer and genetic diseases; therapeutic preparations for enhancing the targeting, delivery, and effectiveness of cancer treatments; t-cells for medical and therapeutic use; cell-based immunotherapeutic treatment by way of genetically modified cells for use in human therapeutics and the treatment of cancer and genetic diseases; pharmaceutical and biological preparations based on gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy for use in human therapeutics, namely, therapeutic pharmaceuticals developed through genome modifications for the treatment of cancer and genetic diseases
Goods and ServicesScientific and medical research services in the field of cell and gene therapies; Scientific and medical research services in the field of cell and gene therapies using engineered viral vectors

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 29, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 29, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKelonia Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events


Event DateEvent Description
Monday, October 2, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Sunday, October 1, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Sunday, October 1, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, June 12, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 12, 2023NON-FINAL ACTION E-MAILED
Monday, June 12, 2023NON-FINAL ACTION WRITTEN
Saturday, June 10, 2023ASSIGNED TO EXAMINER
Tuesday, January 17, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 17, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 17, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 8, 2022TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Tuesday, November 8, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, November 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 3, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 3, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 29, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 27, 2022NEW APPLICATION ENTERED